Market news
Crypto, stocks, forex and macro, aggregated for traders.
AUD/USD Hovers Near Two-Month Low Ahead of China Trade Data
The Australian dollar remains near its lowest level since April 13 against the US dollar, struggling to extend a modest bounce as traders await China's trade balance data.
New Zealand Dollar Eases Ahead of China Trade Balance Data
NZD/USD edges lower to around 0.5800 during Asian hours as the US Dollar holds firm on Middle East uncertainty, with traders eyeing upcoming Chinese trade data.
US Stock Market Cap-to-GDP Ratio Reaches Record 238%
The US stock market capitalization relative to GDP hit an all-time high of 238%, with the market value surging to $75.7 trillion versus an economy of $31.8 trillion.
Japan's Katayama: Stance Unchanged, Ready for Decisive Measures
Japan's Finance Minister Satsuki Katayama reiterated on Tuesday that the government's stance on currency policy remains unchanged and authorities stand prepared to take decisive action if needed.
WTI Slides Below $89.50 as Iran and Israel Agree to Cease Attacks
West Texas Intermediate crude oil edged lower to near $89.40 per barrel during Asian hours after Iran and Israel reportedly agreed to halt attacks. The price fell over 1% in the previous session.
Japan Economy Minister Hopes BoJ Continues Anti-Deflation Cooperation
Japan's Economy Minister Minoru Kiuchi expressed hope that the Bank of Japan will keep cooperating with the government to fight deflation, adding that long-term rates are set by markets based on supply-demand and steady economic factors.
Asia-Pac Stocks Recover on Israel-Iran Halt, Australia Lags
Asia-Pacific stocks rebounded broadly from previous session losses as signs of a halt in Israel-Iran strikes improved sentiment. Australian shares underperformed due to catch-up trading after the holiday break.
Euro weakens below 1.1550 on Middle East uncertainty ahead of ECB rate decision
EUR/USD fell to around 1.1530 in early Asian trading Tuesday, pressured by Middle East uncertainty as markets await the ECB rate decision and US CPI data.
US Full-Time Employment Falls to Pandemic Low as Share of Total Jobs
Full-time employment in the US fell by 79,000 in May to 134.17 million, the lowest since December 2024, marking the second consecutive monthly decline. The share of full-time jobs dropped to 82.4%, matching the pandemic low.
Netanyahu Says War with Iran and Hezbollah Not Over Despite Tehran's Halt
Israeli PM Benjamin Netanyahu said the conflict with Iran and Hezbollah continues, contradicting Tehran's announcement of a halt to strikes. He claimed both groups are weaker than ever.
Gold Edges Lower Below $4,350 as Fed Rate Hike Expectations Grow
Gold price (XAU/USD) trades with mild losses around $4,325 during early Asian trading on Tuesday, pressured by rising bets of a US interest rate hike and uncertainty in the Middle East.
Investor Positioning in Large-Cap Tech at Highest Since October 2025
Investor positioning in US large-cap tech has surged to 1.0 points, the highest since October 2025, after reversing from -0.4 points in late March. The current level exceeds 97% of all readings over the past 16 years.
Market dodges oil shock but rate trap remains set
Monday's bounce was a relief rally, not confirmation of a trend shift. Oil pulled back from geopolitical risks, tech stocks rose, and risk assets stabilized, but the late-day fade indicates lingering caution.
Trump Warns Netanyahu: US May Not Support Israel in Iran Strike
Axios reports that Donald Trump told Israeli Prime Minister Netanyahu that the US might not back Israel if it proceeds with a major strike on Iran, leading Israel to pause the operation on condition that Iran also halts attacks.
Gold ETF Flows Turn Negative in May After Strong Inflows
Gold ETF inflows flipped modestly negative in May, reflecting a range-bound price and a sharp deceleration from previous months, per the World Gold Council.
Silver hits key support as retail bargain hunters step in
Silver has fallen to a key price support level, attracting significant buying from retail bargain hunters after a sharp multi-month setback in precious metals markets.
Y Combinator's Dalal: Crypto Will Be Used by Every Country Unknowingly
At ETH Conference, Y Combinator's Nemi Dalal stated that crypto is more than a niche product and will eventually be used by nearly every country, often without users realizing it.
South Korean Won Gains on Policy Support and Pension Rebalancing
South Korea's Won has outperformed its peers as authorities step up stabilization measures, including new FX rules and tighter oversight of offshore derivatives and National Pension Fund hedging, according to Brown Brothers Harriman.
OpenAI IPO Odds Surge to 48% for $1.5 Trillion Market Cap on Day One
The probability of OpenAI's IPO closing above a $1.5 trillion market cap on the first day of trading has jumped to 48%, following the company's IPO filing. The news highlights the accelerating AI revolution, with three potential trillion-dollar IPOs on the horizon.
USD/CNH Consolidates in 6.7800-6.7950 Range – UOB
UOB strategists note limited upside momentum for USD/CNH after a slight rise to 6.79, expecting consolidation between 6.7800 and 6.7950 for the day.
GBP/JPY Nearly Flat at 213.60, Bulls Target 214.00
GBP/JPY trimmed earlier losses and turned nearly flat near 213.60, down 0.09% amid mixed market sentiment. Bulls are aiming for the 214.00 level.
Nvidia CEO Huang Says to Buy Qualcomm Stock: Report
A tweet from The Kobeissi Letter claims Nvidia CEO Jensen Huang advised buying Qualcomm ($QCOM) stock, adding that he spent the day selling others' stock.
USD/CHF confirms inverted head-and-shoulders, targets 0.80
USD/CHF advanced 0.30% on Monday as an inverted head-and-shoulders pattern was confirmed and price action cleared the 200-day SMA. Technicians eye a potential move toward 0.80.
Gilead and Merck announce positive Phase 3 data for once-weekly HIV treatment
Gilead and Merck reported positive Phase 3 results for their once-weekly oral HIV treatment islatravir/lenacapavir, with primary efficacy endpoints met at week 48 in both ISLEND-1 and ISLEND-2 trials.